CVC exits Theramex to Carlyle, PAI Partners in deal believed to value business at about $1.4bn

Carlyle and PAI Partners have agreed to buy women's health pharmaceutical specialist Theramex from fellow private equity major CVC, in a deal believed to be worth about $1.4bn.